Uric acid: an old actor for a new role by E. Manzato
I M
concentrations. These factors (including high uric acid)
have been mentioned in one or more definitions of the
metabolic syndrome [7]. Recently, much attention has
been paid to the metabolic syndrome due to its possible
role as a risk factor for the development of type 2 diabetes
and cardiovascular disease. The worldwide increase in the
prevalence of obesity and diabetes is a reason not only for
the increasing prevalence of the metabolic syndrome but
also of hyperuricaemia.
Hyperinsulinaemia and insulin resistance lead to ele-
vated serum uric acid levels through both direct and indi-
rect mechanisms, which include increased urate produc-
tion as well as decreased renal urate excretion (probably
due to the stimulating effect of insulin on urate reabsorp-
tion in the renal proximal tubule). Hypertension, use of
some drugs (in particular diuretics) and renal disease are
also associated to increased uric acid concentrations.
The link between uric acid and the progression of vascu-
lar disease has been examined not only in epidemiological
studies but also with experimental investigations [8]. The
possible mechanisms involved in this causal relationship are:
- uric acid may induce a thickening of the glomerular
afferent arteriole, activation of the renin-angiotensin
system, and hence hypertension;
- uric acid may contribute to endothelial dysfunction by
inducing anti-proliferative effects on endothelium and
impairing nitric oxide production;
- uric acid stimulates human vascular smooth muscle cell
proliferation and synthesis of C-reactive protein;
- uric acid may increase platelet adhesiveness and
platelet lysis (a platelet dysfunction may be linked to
endothelial dysfunction);
- hyperuricaemia could promote thrombus formation;
- uric acid may have a role in oxidative stress and in the
formation of free radicals;
- uric acid may enhance oxygenation of low-density
lipoprotein cholesterol and lipid peroxidation.
An independent link between uric acid and endothelial
function has been reported in patients with uncomplicated,
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The study by Montalcini et al. reported recently in this
issue of the journal Internal and Emergency Medicine
contributes to originate new concepts about an old topic,
that is uric acid and its role in vascular disease [1]. They
report that in postmenopausal women serum uric acid lev-
els are directly associated with carotid intima-media
thickness independently of other cardiovascular risk fac-
tors (including the metabolic syndrome). The importance
of this finding is due to the fact that an increased carotid
intima-media thickness is a marker of early atherosclero-
sis and may predict cardiovascular events [2].
Several epidemiological studies have reported a posi-
tive association between serum uric acid concentrations
and cardiovascular diseases [3]. In a recent report it has
been concluded that uric acid is a strong risk factor for
both myocardial infarction and stroke [4]. Elevated urate
concentration is significantly and independently associat-
ed with increased risk of future vascular events in diabet-
ic stroke patients [5].
Therefore, it could be useful for physicians to check
for serum uric acid levels for risk stratification.
However, the role of uric acid as an independent risk
factor for cardiovascular events is still debated [6, 7]. In
fact, other confounding factors such as glucose intoler-
ance, obesity, dyslipidaemia, hypertension, use of diuret-
ics and insulin resistance may play a role in determining
the increased vascular risk associated to elevated uric acid
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untreated essential hypertension, independent of tradition-
al cardiovascular risk factors [9].
Renal excretion of urate is regulated by a member of the
organic anion transporter superfamily (URAT1). A specific
expression of URAT1 on human aortic vascular smooth mus-
cle cells has been reported and this could be a mechanism by
which uric acid enters the human vascular smooth muscle
cell, eventually leading to cardiovascular disease [10].
In patients with congestive heart failure an increased pro-
duction of uric acid is mediated by activation of xanthine
oxidase, a producer of uric acid from xanthine and hypoxan-
thine. Xanthine oxidase is also a source of free radicals and
may contribute to oxidative damage in the myocardium. It
has also been reported that a high serum level of uric acid is
an independent predictor of mortality in patients with con-
gestive heart failure [11]. Therefore, xanthine oxidase inhibi-
tion could be a therapeutic strategy for heart failure and it
may be important to measure serum uric acid as a marker of
oxidative stress in patients with congestive heart failure.
Similarly to homocysteine (an amino acid that has been
linked to increased risk of premature coronary artery dis-
ease and stroke), uric acid may have a toxic effect on the
vasculature by inducing clotting abnormalities and oxida-
tive stress. However, lowering of uric acid in patients with
increased vascular risk has not always been accompanied
by prevention of cardiovascular events [12].
In conclusion, a better understanding of the role of uric
acid in health and in disease states may help physicians to
improve their performance in preventing and treating car-
diovascular disease.
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